Skip to content

RESMED INC

RMD RSMDF

CIK 0000943819

← back to feed
Revenue (TTM)
$5.48B
+9.8% YoY Q3 Apr 2026
Net Income (TTM)
$1.5B
+37.2% YoY Q3 Apr 2026
EPS Diluted (TTM)
$10.27
+37.4% YoY Q3 Apr 2026
Gross Margin
61.2%
Q3 Apr 2026
Operating Margin
34.0%
Q3 Apr 2026
Net Margin
27.5%
Q3 Apr 2026
Free Cash Flow (TTM)
$993.91M
Q3 Apr 2026
Cash
$1.66B
Q3 Apr 2026
Total Debt
$1.28B
Q3 Apr 2026
Shares Outstanding
145.06M sh
Q3 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings